CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹26 Cr | ₹21 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of CONCORD DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹24 Cr |
How is Total Current Liabilities of CONCORD DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 24.64 | |
| Mar2024 | ₹21 Cr | -2.82 | |
| Mar2023 | ₹22 Cr | -8.59 | |
| Mar2022 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹99.4 Cr | -5.5% | 5.2% | 12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -5.5% |
5.2% |
12.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses